Article Sidebar
Submitted
March 22, 2020
Accepted
September 12, 2020
Published
October 9, 2020
Download
Main Article Content
Abstract
None
Keywords
Measles virus
Children
Vaccine
Subacute scelrosing panencephalitis
advocacy
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
Samia, P., Tenembaum, S. ., Hegde, A. ., Idro, R. ., & Wilmshurst, J. M. (2020). Position statement by the ICNA in Support of vaccinating all children against measles virus: Vaccinating children against measles virus. Journal of the International Child Neurology Association, 1(1). https://doi.org/10.17724/jicna.2020.188
References
-
1. Henderson DA. The Measles Epidemic: The Problems, Barriers, and Recommendations. JAMA. 1991 Sep 18;266(11):1547. doi: 10.1001/jama.275.3.224
2. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers. 2016 Dec;2(1):16049.
https://www.cdc.gov/globalhealth/newsroom/topics/measles/index.html
3. Lancella L, Di Camillo C, Vittucci AC, Boccuzzi E, Bozzola E, Villani A. Measles lessons in an anti-vaccination era: public health is a social duty, not a political option. Ital J Pediatr. 2017 Dec;43(1):102. DOI: 10.1186/s13052-017-0420-6
4. Modlin JF, Jabbour JT, Witte JJ, Halsey NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics. 1977 Apr;59(4):505–12.
5. Edwards KM. Maternal immunisation in pregnancy to protect newborn infants. Arch Dis Child. 2019 Apr;104(4):316–9. doi: 10.1136/archdischild-2017-313530
6. Gastañaduy PA, Banerjee E, DeBolt C, Bravo-Alcántara P, Samad SA, Pastor D, Rota PA, Patel M, Crowcroft NS, Durrheim DN. Public health responses during measles outbreaks in elimination settings: Strategies and challenges. Human Vaccines & Immunotherapeutics. 2018 Sep 2;14(9):2222–38. doi: 10.1080/21645515.2018.1474310
7. Centers for Disease Control (CDC). Public-sector vaccination efforts in response to the resurgence of measles among preschool-aged children--United States, 1989-1991. MMWR Morb Mortal Wkly Rep. 1992 Jul 24;41(29):522–5.
8. Landrigan PJ. What causes autism? Exploring the environmental contribution: Current Opinion in Pediatrics. 2010 Apr;22(2):219–25. doi: 10.1097/MOP.0b013e328336eb9a
9. Hornig M, Briese T, Buie T, Bauman ML, Lauwers G, Siemetzki U, Hummel K, Rota PA, Bellini WJ, O'Leary et al. Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study. Cookson MR, editor. PLoS ONE. 2008 Sep 4;3(9):e3140. doi: 10.1371/journal.pone.0003140
10. Lo NC, Hotez PJ. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. 2017 Sep 1;171(9):887. doi: 10.1001/jamapediatrics.2017.1695
11. Nic Lochlainn LM, de Gier B, van der Maas N, Strebel PM, Goodman T, van Binnendijk RS, de Melker HE, Hahné SJM. Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis. Lancet Infect Dis. 2019 Nov;19(11):1246-1254. doi: 10.1016/S1473-3099(19)30396-2
12. Coughlin M, Beck A, Bankamp B, Rota P. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Viruses. 2017 Jan 19;9(1):11. doi: 10.3390/v9010011
13. Jafri SK, Kumar R, Ibrahim S. Subacute sclerosing panencephalitis - current perspectives. PHMT. 2018 Jun 9:67–71. doi: 10.2147/PHMT.S126293
14. Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, Smith D, Hwaiwhanje I, Siba PM, Davis TM. Subacute Sclerosing Panencephalitis in Papua New Guinean Children: The Cost of Continuing Inadequate Measles Vaccine Coverage. Powers AM, editor. PLoS Negl Trop Dis. 2011 Jan 4;5(1):e932. doi: 10.1371/journal.pntd.0000932
References
1. Henderson DA. The Measles Epidemic: The Problems, Barriers, and Recommendations. JAMA. 1991 Sep 18;266(11):1547. doi: 10.1001/jama.275.3.224
2. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers. 2016 Dec;2(1):16049.
https://www.cdc.gov/globalhealth/newsroom/topics/measles/index.html
3. Lancella L, Di Camillo C, Vittucci AC, Boccuzzi E, Bozzola E, Villani A. Measles lessons in an anti-vaccination era: public health is a social duty, not a political option. Ital J Pediatr. 2017 Dec;43(1):102. DOI: 10.1186/s13052-017-0420-6
4. Modlin JF, Jabbour JT, Witte JJ, Halsey NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics. 1977 Apr;59(4):505–12.
5. Edwards KM. Maternal immunisation in pregnancy to protect newborn infants. Arch Dis Child. 2019 Apr;104(4):316–9. doi: 10.1136/archdischild-2017-313530
6. Gastañaduy PA, Banerjee E, DeBolt C, Bravo-Alcántara P, Samad SA, Pastor D, Rota PA, Patel M, Crowcroft NS, Durrheim DN. Public health responses during measles outbreaks in elimination settings: Strategies and challenges. Human Vaccines & Immunotherapeutics. 2018 Sep 2;14(9):2222–38. doi: 10.1080/21645515.2018.1474310
7. Centers for Disease Control (CDC). Public-sector vaccination efforts in response to the resurgence of measles among preschool-aged children--United States, 1989-1991. MMWR Morb Mortal Wkly Rep. 1992 Jul 24;41(29):522–5.
8. Landrigan PJ. What causes autism? Exploring the environmental contribution: Current Opinion in Pediatrics. 2010 Apr;22(2):219–25. doi: 10.1097/MOP.0b013e328336eb9a
9. Hornig M, Briese T, Buie T, Bauman ML, Lauwers G, Siemetzki U, Hummel K, Rota PA, Bellini WJ, O'Leary et al. Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study. Cookson MR, editor. PLoS ONE. 2008 Sep 4;3(9):e3140. doi: 10.1371/journal.pone.0003140
10. Lo NC, Hotez PJ. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. 2017 Sep 1;171(9):887. doi: 10.1001/jamapediatrics.2017.1695
11. Nic Lochlainn LM, de Gier B, van der Maas N, Strebel PM, Goodman T, van Binnendijk RS, de Melker HE, Hahné SJM. Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis. Lancet Infect Dis. 2019 Nov;19(11):1246-1254. doi: 10.1016/S1473-3099(19)30396-2
12. Coughlin M, Beck A, Bankamp B, Rota P. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Viruses. 2017 Jan 19;9(1):11. doi: 10.3390/v9010011
13. Jafri SK, Kumar R, Ibrahim S. Subacute sclerosing panencephalitis - current perspectives. PHMT. 2018 Jun 9:67–71. doi: 10.2147/PHMT.S126293
14. Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, Smith D, Hwaiwhanje I, Siba PM, Davis TM. Subacute Sclerosing Panencephalitis in Papua New Guinean Children: The Cost of Continuing Inadequate Measles Vaccine Coverage. Powers AM, editor. PLoS Negl Trop Dis. 2011 Jan 4;5(1):e932. doi: 10.1371/journal.pntd.0000932
2. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers. 2016 Dec;2(1):16049.
https://www.cdc.gov/globalhealth/newsroom/topics/measles/index.html
3. Lancella L, Di Camillo C, Vittucci AC, Boccuzzi E, Bozzola E, Villani A. Measles lessons in an anti-vaccination era: public health is a social duty, not a political option. Ital J Pediatr. 2017 Dec;43(1):102. DOI: 10.1186/s13052-017-0420-6
4. Modlin JF, Jabbour JT, Witte JJ, Halsey NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics. 1977 Apr;59(4):505–12.
5. Edwards KM. Maternal immunisation in pregnancy to protect newborn infants. Arch Dis Child. 2019 Apr;104(4):316–9. doi: 10.1136/archdischild-2017-313530
6. Gastañaduy PA, Banerjee E, DeBolt C, Bravo-Alcántara P, Samad SA, Pastor D, Rota PA, Patel M, Crowcroft NS, Durrheim DN. Public health responses during measles outbreaks in elimination settings: Strategies and challenges. Human Vaccines & Immunotherapeutics. 2018 Sep 2;14(9):2222–38. doi: 10.1080/21645515.2018.1474310
7. Centers for Disease Control (CDC). Public-sector vaccination efforts in response to the resurgence of measles among preschool-aged children--United States, 1989-1991. MMWR Morb Mortal Wkly Rep. 1992 Jul 24;41(29):522–5.
8. Landrigan PJ. What causes autism? Exploring the environmental contribution: Current Opinion in Pediatrics. 2010 Apr;22(2):219–25. doi: 10.1097/MOP.0b013e328336eb9a
9. Hornig M, Briese T, Buie T, Bauman ML, Lauwers G, Siemetzki U, Hummel K, Rota PA, Bellini WJ, O'Leary et al. Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study. Cookson MR, editor. PLoS ONE. 2008 Sep 4;3(9):e3140. doi: 10.1371/journal.pone.0003140
10. Lo NC, Hotez PJ. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. 2017 Sep 1;171(9):887. doi: 10.1001/jamapediatrics.2017.1695
11. Nic Lochlainn LM, de Gier B, van der Maas N, Strebel PM, Goodman T, van Binnendijk RS, de Melker HE, Hahné SJM. Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis. Lancet Infect Dis. 2019 Nov;19(11):1246-1254. doi: 10.1016/S1473-3099(19)30396-2
12. Coughlin M, Beck A, Bankamp B, Rota P. Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. Viruses. 2017 Jan 19;9(1):11. doi: 10.3390/v9010011
13. Jafri SK, Kumar R, Ibrahim S. Subacute sclerosing panencephalitis - current perspectives. PHMT. 2018 Jun 9:67–71. doi: 10.2147/PHMT.S126293
14. Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, Smith D, Hwaiwhanje I, Siba PM, Davis TM. Subacute Sclerosing Panencephalitis in Papua New Guinean Children: The Cost of Continuing Inadequate Measles Vaccine Coverage. Powers AM, editor. PLoS Negl Trop Dis. 2011 Jan 4;5(1):e932. doi: 10.1371/journal.pntd.0000932